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The presence of immune cells in the placental bed is important for both mother and child. Although
various immune cells can be found in the placental bed, such as regulatory T cells and dendritic cells,
uterine NK cells and macrophages are the most prominent immune cells in the placental bed in early
pregnancy. uNK cell and macrophage numbers in the placental bed decrease in the third trimester. These
cells seem to be speciﬁcally adapted for their function and environment. uNK cells do not show cytotoxic
activity, but are producers of cytokines, growth factors and many other factors. uNK cell function is
regulated by inhibitory and activating receptors binding to HLA class I on trophoblast cells. uNK cells are
also involved in regulating trophoblast invasion. Macrophages mainly show an M2-like phenotype and
also produce cytokines and various other factors. They are important in phagocytosis of various cells and
cell debris in the placental bed. Both cell types are also involved in angiogenesis and spiral artery
remodeling in the placental bed. In this review we will elaborate on the most important functions of uNK
cells and macrophages in the placental bed in humans. We will also discuss animal models, since they
may provide clues for function of uNK cells and macrophages in humans.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
During pregnancy, the development of the placenta and the
placental bed is important for fetal development. The healthy
development of the placental bed not only depends on invasion of
fetal trophoblast but also on the presence of immune cells, such as
uterine NK cells and macrophages. Since the fetal trophoblast is
semi-allogeneic, it seems inevitable that the local immune
response at the implantation side has to change in pregnancy. This
may be especially important in species with a hemochorial placenta
(for instance humans and rodents). The hemochorial placenta is the
most invasive type of placenta, in which there is intimate contact
between fetal tissue (trophoblast) and the maternal immune sys-
tem both in the placental bed as well as in the fetal placenta [1]. In
this type of placenta, immediately after implantation of the blas-
tocyst, when the endometrium is inﬁltrated by fetal trophoblasts
and transformed into the decidua, the number of immune cells will
increase at the implantation site [2]. This is important for properivision of Medical Biology,
rsity Medical Center Gronin-
nds.
r Ltd. This is an open access articleregulation of trophoblast invasion and spiral artery remodeling and
thus for placentation. This inﬁltration of immune cells is also
important in order to protect the integrity of the uterus and the
mother. The immune composition of the decidua is unique [2],
since it largely differs from the composition of immune cells in
blood and other organs. Most of the leukocytes in the placental bed
are innate immune cells, i.e. NK cells and macrophages, which may
comprise about 90% of all leukocytes [2,3]. Only about 10% of the
immune cells are T cells in early human pregnancy [2,4]. A few
dendritic cells, granulocytes and B cells can be found [2,5]. Since
uterine NK cells and macrophages are the most prominent cells in
the placental bed, the present reviewwill focus on the roles of these
cells at the maternal fetal interface. We will mainly focus on
humans, but we will discuss rodent models since these animals are
often used as models for the human placental bed.2. Human fetal maternal interface
The placenta is important in maternal-fetal exchange of nutri-
ents and gases. In a hemochorial placenta, this is possible through
fetal villous tissue bathing in maternal blood [6]. To accomplish the
maternal blood circulation in the placenta, during placentation,
several changes have to take place in the uterus. First, theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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decidua basalis. Then placental villous trophoblasts, differentiate
into extravillous trophoblasts, which consists of 2 populations:
interstitial and extravascular trophoblast. First interstitial tropho-
blasts invade into the decidua. Then, endovascular trophoblasts
invade into the decidua as well as into the inner third of the
myometrium and extensively remodel the uterine spiral arteries.
During this process the endovascular trophoblasts become
embedded intramurally in the ﬁbrinoid layer, which replaces the
original vascular smooth muscles [7]. Finally, reendothelialization
occurs [7]. At the end of this process, the spiral arteries are
remodeled into large diameter conduit vessels with low resistance
assuring a constant blood supply to the intervillous space of the
placenta [7]. The placental bed, consisting of both decidual and
myometrial segments, and containing the (remodeled) spiral ar-
teries, is thus important for blood supply into the intervillous space
[7]. The remodeling of the spiral arteries is accomplished by the
presence of both fetal trophoblast cells and maternal immune cells
[7] (see also Fig. 1, showing the placental bed at the time of
trophoblast invasion and spiral artery remodeling, 16e20 weeks of
pregnancy).3. Rodent fetal maternal interface
Like humans, rodents also have a hemochorial placenta.
Maternal-fetal exchange takes place in the labyrinth. Rodents are
often used as animal models to study pregnancy and pregnancy
related problems. Unique to the rodent placental bed is the
development of the mesometrial triangle [8]. This structure de-
velops on the mesometrial side of the rodent uterus at about
midgestation. In this structure, decidualized cells as well as manyFig. 1. Placental bed with spiral arteries and immune cells in humans (between weeks 16e
basalis and the inner part of the myometrium, which are both invaded by trophoblast and
between week 16 and 20) aligned with trophoblast until the myometrium, supply blood into
and is therefore not seen in this ﬁgure.
The rodent placental bed consists of the decidua basalis and the mesometrial triangle, the e
supply blood into the arterial channel (or channels), which then traverse the labyrinth and m
be found throughout the decidua and mesometrial triangle. In the rat, trophoblasts invade in
and trophoblast invasion. In the mouse, extravillous trophoblasts only invade into the dec
triangle is therefore dependent on the immune cells. Note that re-endothelialization takesimmune cells, mainly uNK cells and macrophages, are present. This
structure also contains spiral arteries. The spiral arteries traverse
the decidua basalis and then converge to form 1e4 centrally located
arterial channels [8]. The channels then traverse the labyrinth and
maternal blood ﬂow into the labyrinth is from the embryonic site
[8]. Themesometrial triangle is considered as the rodent equivalent
of the deeper part of the human placental bed. Although the
mesometrial triangle is present in both rats and mice, trophoblast
invasion into this gland is different between these species. In rats,
deep trophoblast invasion into the mesometrial triangle is found
until the myometrium [9], while in mice trophoblast invasion
beyond the decidua is not found [8]. However, in both rats and
mice, spiral artery remodeling in the mesometrial triangle is found
[8,9] (see also Fig. 1). Many studies on mice have been done on
spiral artery remodeling in the decidua, since in this part of the
mouse placental bed both trophoblast and immune cells are pre-
sent. Themesometrial triangle in the rat is often used as amodel for
deep spiral artery remodeling in humans, since in rats in the
mesometrial triangle both trophoblast and immune cells are
present.4. Immune cells in the decidua in human pregnancy
The placental bed contains many immune cells during preg-
nancy. Immunohistochemical studies have shown that during early
pregnancy 30e40% of all cells in the decidua are leukocytes [10].
Leukocytes are, however, present in the placental bed during all
stages of pregnancy [3,11]. These leukocytes consist of uNK cells,
macrophages and also T lymphocytes [3,10,11]. Most T lymphocytes
present during pregnancy are CD8 cytotoxic T lymphocytes [3,10],
although Kwan et al. found that only about 50% of T lymphocytes20) and rodents (around day 18). The placental bed of humans consists of the decidua
immune cells. The remodeled spiral arteries, which are, at this time of pregnancy (i.e
the intervillous space. Note that re-endothelialization takes place in the third trimester
quivalent of the deeper part of the placental bed in humans. Remodeled spiral arteries
aternal blood ﬂows into the labyrinth from the fetal side. In rodents, immune cells can
to the decidua and mesometrial triangle and are important for spiral artery remodeling
idua, not into the mesometrial triangle. Spiral artery remodeling in the mesometrial
place later in pregnancy and is not seen yet.
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increase towards the third trimester of pregnancy [3,11]. Most
prominent leukocyte populations in the placental bed seem to be
the uNK cells [3,10,12], and the macrophages [3,10]. Higher
numbers of these cell populations are found in the placental bed
during the ﬁrst and second trimester as compared with the third
trimester [3,11].
4.1. Uterine NK cells
NK cells were originally described as lymphocytes with natural
cytotoxicity against tumor cells [13]. It has, however, since long
been established that NK cells are a lymphocyte population, sepa-
rate from T and B cells, with cytotoxic and cytokine producing
effector functions [13]. In humans, they are recognized by CD56
expression and lack of expression of CD3 [14]. Two populations of
circulating NK cells can be distinguished in humans, i.e. the cyto-
toxic NK cells, which are CD56dim/CD16þ and represent about 90%
of all circulating NK cells in humans and the cytokine producing NK
cells, which are CD56þþ/CD16- [13]. They are suggested to be a
regulatory subset.
Uterine NK cells (uNK) cells in the human endometrium and
placental bed are CD56þþ/CD16-. They, however, are different
from the CD56þþ/CD16- NK cell population in the blood, since they
are highly granulated, while peripheral blood CD56þþ/CD16- NK
cells are not granulated. They also express different markers as
compared to blood NK cells [2]. uNK cells are already present in the
endometrium at the menstrual cycle: they are present in small
numbers in the proliferative and early secretory phase endome-
trium, while numbers increase in the late secretory phase of the
menstrual cycle [4,10]. The numbers of uNK cells increase during
early pregnancy and they are the dominating population in the ﬁrst
trimester decidua (about70% of all leukocytes) [4,10]. Although
some studies have shown that uNK cells decrease dramatically in
number after the ﬁrst trimester and are nearly absent in the second
and third trimester [12], other studies, however, do suggest that
they are present during all stages of pregnancy [3,15]. uNK cells are
usually found in the vicinity of invading fetal trophoblast cells [16],
and in the vicinity of spiral arteries being remodeled [17].
4.1.1. Function of uNK cells
The exact in vivo function of uterine NK cells is not clear yet.
However, their location suggest that they are involved in tropho-
blast invasion and spiral artery remodeling. In vitro studies have
been performed to evaluate the effect of uNK cells on trophoblast
invasion. These in vitro data showed inconsistent results, since
studies showed that in vitro uNK cells increased [18,19], decreased
[20] or not affected [19] trophoblast invasion. These inconsistencies
between the studies may be due to the time of pregnancy at which
the uNK were isolated, since uNK isolated fromweek 8e10 did not
affect trophoblast invasion, while uNK cells isolated from days
12e14 did increase trophoblast invasion in vitro [19]. Also differ-
ences in methods between the studies may have affected the re-
sults, since isolated trophoblast are used [18], but also villous
explants [19,20] to study trophoblast invasion.
Knowledge on human uNK cell function is mainly derived from
studies performed using isolated uNK from early pregnancy
decidual tissue, retrieved after elective abortion. Unfortunately,
placental bed is lacking in this material and it is not feasible to get
material from other gestational ages, apart from after delivery. It
has been shown since long that in early pregnancy uNK cells do
exhibit cytotoxic activity against an NK cell target K562 [21]. This
cytotoxicity is, however, lower than that of peripheral NK cells [21].
uNK cells do not show cytotoxicity against extravillous trophoblast
cells [22]. It is thought that the main function of uNK cells is toproduce cytokines, growth factors, angiogenic factors and other
factors. Indeed, already in the 1990's it was shown that uNK cells
produce a variety of cytokines, such as Tumor necrosis factor a
(TNFa), interleukin-10, interleukin-1b, Transforming growth factor
b (TGFb) and interferon g (IFNg) [23] as well as Macrophage-Colony
stimulating factor (M-CSF) or Granulocyte macrophage-colony
stimulating factor (GM-CSF) [18]. In later studies it was shown
that uNK cells also produce angiogenic growth factors, such as
vascular endothelial growth factor-C (VEGF-C), Placental growth
factor (PlGF) and angiopoietin-1 [24,25] and proteases, such as
metallomatrix proteases (MMPs) [26].
uNK cell function seems to be regulated by their expression of
NK cell receptors, such as NKG2A, LILRB1 and receptors of the KIR
family [27]. These receptors bind to unique forms of HLA class I,
HLA-C, E and G, expressed by extravillous trophoblast (EVT) [28].
The communication between EVT expressing HLA and KIR
expressing uNK has been evaluated in various studies. For instance,
growth factor production by uNK cells seems to depend on direct
contact between uNK cells and trophoblast, suggesting that
receptor-ligand interactions are needed [29]. The polymorphic
killer cell immunoglobulin-like receptors (KIRs) seem to be
important in balancing the NK activating and inhibitory signaling
[30], since it has been shown that binding of KIR2D with HLA-C
modulates uNK responses and may alter trophoblast migration
and spiral artery remodeling [27]. Speciﬁc combinations of these
receptor-ligand bindings are important for healthy pregnancy,
since genetic association studies have suggested that allor-
ecognition of fetal HLA-C2 of the KIR B haplotype might be
important for normal placental development. On the other hand,
allorecognition of HLA-C2 of the maternal KIR AA genotype
increased the risk for preeclampsia in various ethnic populations
[31].
In spiral artery remodeling two different steps can be identiﬁed.
The ﬁrst step is the loss of the musculo-elastic structure and the
formation of endothelial cell layer breaks [32]. This ﬁrst process
takes place in the absence of trophoblast cells, but in the presences
of uNK cells and macrophages, suggesting an important role for
these immune cells in this ﬁrst step of spiral artery remodeling
[17,33,34]. In the second step, fetal trophoblasts, especially endo-
vascular trophoblast, are attracted towards the arteries, transiently
replacing the endothelial lining in the decidua and partly in the
myometrium. At this time, also many uNK cells are still found in the
vicinity of the spiral arteries, suggesting a role for these cells at this
second step as well [17].
4.1.2. Origin of uNK cells
The origin of uNK cells and the reason for their increase at the
fetal maternal interface during pregnancy is not well established.
However, several mechanisms have been proposed. The ﬁrst
mechanism is the recruitment of peripheral blood NK cells, i.e. the
CD56þþ/CD16-cells that differentiate locally into uNK cells [35,36].
This suggestion is supported by the fact that decidual cells and
trophoblasts secrete large amounts of NK cell chemoattractants,
such as IP-10, MCP-1 [35]. The second suggestion is that uNK cells
mature from endometrial NK cells in response to pregnancy-
associated factors, such as hormones (progesterone) or IL-15 [37].
Another suggestion is that uNK cells differentiate from hemato-
poietic precursors present in the decidua in response to decidual
stromal factors [35,38]. These three mechanisms could also act in
parallel.
4.1.3. uNK cells in rodent models
Much of the knowledge on the role of uNK cells in the devel-
opment of the placental bed arises frommouse studies. Although in
mice uNK cells only appear in the decidua basalis by day 6.5, and
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uNK cells, murine uNK cells are activated [39], express interferon
gamma [40] and the mouse equivalent of KIR receptor, LY49 [41].
They also express growth factors, such as VEGF A and placental
growth factor [42,43]. Many studies in mice have shown an
important role of uNK cells in spiral artery remodeling in the
decidua, which in the mouse, decidual spiral artery remodeling
occurs between day 8.5 and day 10.5 of pregnancy (mouse preg-
nancy lasts for 19e20 days) [40]. uNK cells play a major role in this
spiral artery remodeling, since NK cell deﬁcient mouse lack spiral
artery remodeling and have abnormal decidual and myometrial
structures at midgestation [44,45]. Indeed, after reconstitution of
NK cells in NK cell deﬁcient mice, spiral artery remodeling was
normal [46]. It seems to be especially IFNg production by uNK cells,
that is important for the spiral artery remodeling, since systemic
administration of IFNg to NK cell deﬁcient mice also resulted in
normal spiral artery remodeling [40,47,48]. Interestingly, mouse
uNK cells do not limit trophoblast invasion into the decidua [46].
Spiral artery remodeling has also been shown in rats [9,49]. In
contrast to the mouse, deep trophoblast invasion in the rat into the
mesometrial triangle, up to themyometrium has been found [9,50],
which makes the rat a good model for spiral artery remodeling in
the deeper parts of the placental bed in humans. The role for uNK
cells in spiral artery remodeling and trophoblast invasion has been
less well characterized in rats as compared with mice. However, in
contrast to mice, in rats uNK cells seem to interfere with tropho-
blast invasion, especially in the mesometrial triangle. This is for
instance apparent from the locations of uNK cells vs interstitial
trophoblast. Staining of uNK cells and trophoblast in consecutive
sections of the mesometrial triangle on days 15, 17 and 20 of rat
pregnancy shows that trophoblast invasion seemed to follow the
demise of uNK cells in the direction of the myometrium (see also
Fig. 2). This suggests that uNK cells regulate interstitial trophoblast
invasion. They also seem to regulate intravascular trophoblast in-
vasion, since depletion of NK cells in early pregnancy, resulted inFig. 2. Mesometrial triangle of 15, 17 and 20 days pregnant rats, stained for trophoblasts (bl
according to protocols described by Spaans et al. [9]). At day 15, little interstitial trophob
throughout the whole mesometrial triangle, mainly found in a cuff around the spiral arter
triangle towards the myometrium (MYO), while uNK cells have retracted into the directio
associated with even further invasion of the interstitial trophoblast into the mesometrial tincreased endovascular trophoblast invasion at day 13 [51]. Un-
fortunately, no studies with NK cell depletion have been done in
pregnant rats beyond day 13 in order to study the effect of uNK on
interstitial trophoblast invasion in healthy pregnant rats.
A role for uNK cells in spiral artery development and remodeling
has been shown by Chakraborty et al. [51]. These authors have
shown that uNK cells promote uterine spiral artery growth towards
the ectoplacental cone [51] and that uNK cells cause a partial
disruption of the spiral artery tunicamedia integrity [51]. Data from
our lab also indicated a role for uNK cells in spiral artery remod-
eling, since we found partly remodeled spiral arteries in the mes-
ometrial triangle of day 15 of pregnancy in the presence of uNK
cells, but without the presence of interstitial of trophoblast (see
Fig. 3). However, apparently, for complete spiral artery remodeling
in the mesometrial triangle in the rat, endovascular trophoblast
invasion is needed [51,52].4.2. Uterine macrophages
Macrophages can be found in all tissues and they are important
in the detection, ingestion and processing of foreign material, dead
cells and other debris [53]. They are derived from monocytes [53],
which are recruited into tissues to replenish steady state macro-
phages or they are recruited to inﬂammatory tissue [53]. Macro-
phages do not only play a role in inﬂammation, they also have an
important role in the resolution of inﬂammation [53]. Several
subsets of macrophages have now been described. Some years ago,
they were subdivided into 2 groups: M1 (classically activated
macrophages) and M2 (alternatively activated macrophages) [54].
M1 macrophages are microbicidal and inﬂammatory, while M2
macrophages are immunomodulatory, inducing tolerance and
resolution of inﬂammation [54]. However, more recently it was
found that these 2 populations are extreme ends of polarization
and many different intermediate types of macrophages can be
found [55].ack staining; top row) or NK cells (black staining, lower row) (all sections were stained
last invasion is observed in the mesometrial triangle, while NK cells are prominent
ies (SA). At day 17, interstitial trophoblasts have further invaded into the mesometrial
n of the myometrium. At day 20, there is a further demise of the uNK cells, which is
riangle until the myometrium. (dec ¼ decidua).
Fig. 3. Spiral arteries (SA) in the mesometrial triangle of day 15 pregnant rats stained for trophoblast (left photograph), uNK cells (middle photograph) and a-smooth muscle actin
(SMA) (right photograph). (sections are stained according to protocols described by Spaans et al. [9]). It can be seen that trophoblast staining is absent in the spiral artery at the top
right of the left photograph (red arrow), while the same spiral artery in the middle photograph shows an abundant uNK cells cuff. The right photograph shows that despite the
absence of trophoblasts, but in the presence of uNK cells, the smooth muscle cells have partly disappeared, indicating spiral artery remodeling.
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endometrium of non-pregnant women, although they ﬂuctuate
during the menstrual cycle [10]. It seems therefore likely that these
cells are under hormonal control [56]. After fertilization, the
number of uterinemacrophages immediately increases [57], so that
20e30% of all decidual leukocytes are macrophages in early preg-
nancy [58]. Although macrophages are present in the placental bed
at all times during pregnancy [59], the number of decidual mac-
rophages varywith gestational agewith the highest numbers found
in the ﬁrst and second trimester [60].4.2.1. Macrophage function
Various studies have focused on speciﬁc functions of macro-
phages in the human placental bed and these cells seem to have
various roles during pregnancy. They play a role in spiral artery
remodeling and trophoblast invasion [59,61], but they may also
play a role in blastocyst implantation [62] and in protecting the
fetus against intrauterine infection [63]. The putative role of mac-
rophages in spiral artery remodeling is shown by their presence
around spiral arteries in the human placental bed. They can spe-
ciﬁcally be found in the vicinity of spiral arteries that show
disruption and disorganization of vascular smoothmuscle cells and
endothelial cells, while no extravillous trophoblast was present at
that time [17]. This suggests that macrophages prepare spiral ar-
teries for further remodeling by trophoblast cells. In accordance
with this role, decidual macrophages produce many factors asso-
ciated with angiogenesis and tissue remodeling [64,65]. During
spiral artery remodeling by trophoblast, apoptotic trophoblast cells
can be found [66]. One of the roles of the macrophages present
around spiral arteries at that time may be to engulf these apoptotic
cells, thereby preventing the release of proinﬂammatory sub-
stances into the decidua [67].
Since placental bed macrophages express various M2 markers,
such as CD206, CD163 and DC-sign, they seem to be M2-like
macrophages, i.e. immunomodulatory macrophages [68,69]. They
may, however, not be the typical M2 macrophages, since they are
not induced by Th2 cytokines, but by M-CSF and IL-10 in in vitro
studies [70]. One study suggested the presence of two macrophage
subpopulations in the early decidua (6e12 weeks of pregnancy): a
more proinﬂammatory and a more regulatory subset, which washigher in number as compared with the proinﬂammatory subset
[71].
As indicated above, also at the end of pregnancy, macrophages
can be found in the placental bed. Although it is recognized that
these macrophages are of the M2 phenotype [72], the exact role of
these decidual macrophages at the end of pregnancy remains to be
established. It seems likely, however, that similar to early preg-
nancy, also in late pregnancy they are involved in clearance of
apoptotic cells and immunoregulation.4.2.2. Origin of decidual macrophages
Although it has always been thought that monocytes are the
sole precursors of tissue macrophages, for many tissues, such as
liver, lung, brain, it has now been shown that macrophages arise
from macrophage progenitors from the yolk sac [73e75]. These
precursors migrate to the various tissue during embryonic life and
are maintained in these tissues during adult life [75]. Mucosal tis-
sues, such as the decidua, seem to be an exception, since macro-
phages in these tissues appear to be mainly derived from blood
monocytes [74]. Monocytes are short-lived circulating cells,
comprising about 5e10% of the circulating blood leukocytes [53]. In
humans, three monocyte subsets are found, which differ in many
aspects [53]. Classical monocytes, representing 90e95% of all
monocytes, arise from the bone marrow and mature in the circu-
lation via intermediate monocytes into non-classical monocytes
[76], the other 2 monocyte subsets. Classical monocytes are
phagocytes and generate reactive oxygen species and produce cy-
tokines, while non classical monocytes are only weak phagocytes,
but more efﬁcient producers of pro-inﬂammatory cytokines [53].
Non-classical monocytes patrol the endothelium to survey for
endothelial cell damage and infection [53]. Non-classical mono-
cytes have been shown to be increased in various inﬂammatory
diseases [53] and also in pregnancy [77,78]. In rodents, also classical
and non-classical monocytes have been described [77,79]. The
functions of the subtypes appear similar between humans and
rodents.
It is unknown whether macrophages in the placental bed arise
from classical or non-classical monocytes during pregnancy.
Tagliani et al. have shown that in mice mainly classical monocytes
and not non-classical monocytes, inﬁltrate into the decidua in early
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sical monocytes during pregnancy is due to an increased inﬁltration
of these monocytes into the decidua. Recently, it has also been
suggested that classical monocytes preferentially differentiate into
M1 macrophages, and non-classical monocytes preferentially
differentiate into M2 macrophages [81]. Since macrophages in the
placental bed are mainly of the M2-like type, this suggests that
non-classical monocytes would preferentially invade into the
decidua. Further studies are therefore needed to evaluate the role of
the different monocyte subsets in populating the macrophages in
the placental bed.
4.2.3. Decidual macrophages in rodent models
Since it is difﬁcult to study the role of macrophages in the
placental bed in humans, the use of animal models help in under-
standing the function of macrophages in the decidua. In mice,
macrophages are present in the decidua and myometrium [82]. In
early pregnancy in mice they are found scattered throughout the
decidua [83]. At the end of pregnancy, macrophages are the largest
population of immune cells in the mouse decidua [84]. Not much is
known about the function of these cells in the mouse placental bed.
In the rat, we and others found many macrophages in the
mesometrial triangle [9,85]. They were found throughout the
interstitium but also around the spiral arteries, but with no
apparent relation with the state of the remodeling of the arteries.
Only a few M2 macrophages were found in the mesometrial tri-
angle of healthy pregnant rats at the end of pregnancy [9]. These
results indicate that in the rat, macrophages may not have a
prominent role in spiral artery remodeling in the mesometrial tri-
angle. It could indicate that they are important for phagocytosis of
apoptotic cells and debris released during the spiral artery
remodeling. Further studies into these placental bed cells are
necessary and help in deﬁning the role of placental bed macro-
phages in humans.
5. NK cells and macrophages in cancer
Being part of a special edition of Placenta following the Lumps
and Bumps Conference 2016, this last paragraph will focus on the
similarities and differences between immune cells in the decidua
and in tumors. Trophoblast cells are often compared with tumor
cells, since they invade the decidual tissue, like tumor cells invade
normal tissue [86]. As described above, the decidua contains a lot of
immune cells, mainly uNK and macrophages. Also tumors are
inﬁltrated by immune cells, mostly T cells [87], but also NK cells and
macrophages [88,89].
In contrast to the placental bed, tumors contain only a low
number of NK cells, which suggests that NK cells do not efﬁciently
home to tumor tissue [90]. As in the decidua, in some tumors it has
been shown that the cytokine producing NK cells subset
(CD56þþCD16- NK cells) are enriched in the tumor [91,92]. This
indicates that these NK cells mainly produce cytokines, and do not
exert direct tumor cell killing. Indeed, the NK cells present in a
tumor may have a distinct phenotype: depending on the cancer
type, they may express increased numbers of inhibitory receptors
[93] or decreased numbers of activating receptors [92]. Commu-
nication between tumor cells and NK cells seem to be important for
regulating NK cells function. For instance, the NK cell activating
receptor, DNAM-1, seems to be downregulated by ovarian carci-
noma cells [92]. Another example of tumor cells regulating NK cell
function is the induction of the production of regulatory cytokines
and diminished granule mobilization, cytotoxicity and IFNg pro-
duction by NK cells after binding to CD137 on acute myeloid leu-
kemia cells. These data suggest that tumors do not promote
inﬁltration of NK cells and if NK cells do inﬁltrate, tumor cells downregulate their tumor killing activity [94]. This is partly similar to the
situation in the decidua: although the decidua promotes inﬁltration
of NK cells, trophoblasts present in the decidua do regulate uNK cell
function to make to make sure they do not kill trophoblast cells.
Macrophages are another important cell type in the tumor
environment. They are usually referred to as tumor associated
macrophages (TAM) and are the most abundant immune cells in
solid tumors [95]. Their presence correlates with worse disease
prognosis and higher frequency of metastasis in various cancers
[96e98]. As in the placental bed, in tumors, most macrophages are
derived from circulating monocytes, and thus from hematopoietic
precursors [89,99]. The role of TAMs in the tumor may vary,
depending on the tumor type. In colorectal tumors, for instance,
TAMs are proinﬂammatory and play an antitumor role [100,101].
The antitumor effect may be due to the production of various
proinﬂammatory cytokines by the TAMs, which activate cytotoxic T
cells, and induce an antitumor immune response [100]. However, in
most tumor types, such as breast cancer, ovarian cancer, cervical
cancer and lung cancer, TAMs show an M2-like phenotype,
expressing M2 markers, like CD163 or C-type lectin domains
[102,103]. The M2-like phenotype is induced and maintained by
other immune cells in the tumor (such as T cells) as well as by tu-
mor cells [104,105]. The M2 TAMs in tumors promote angiogenesis
[96], lymphangiogenis [106] tumor growth [107e109]. Thus TAMs,
like decidual macrophages, are mainly recruited from monocytes,
are mainly of the M2-like phenotype and are angiogenic and
immunoregulatory. Similar to decidual macrophages, which pro-
mote placental growth and development, TAMs promote tumor
growth and development.
6. Conclusion
Although in the past, it was thought that uNK cells and mac-
rophages in the placental bed were dangerous for pregnancy, it is
now known that these cells are very important for implantation
and normal development of the placental bed and thus the
placenta. Both cell types are found in the vicinity of EVT and spiral
arteries, suggesting that they have a role in trophoblast invasion
and spiral artery remodeling. uNK cell function may depend on the
presence of extravillous trophoblast, which express speciﬁc HLA
class I molecules, which bind to inhibitory and activating receptors
on uNK cells. The exact mechanisms by which these cells affect the
vascular wall remain to be established. Both cells types aid in spiral
artery remodeling by producing cytokines, growth factors and
other factors. Macrophages, may also help in spiral artery remod-
eling by clearance of apoptotic cells and cell debris. Both cell types
also have other functions in the decidua, such as angiogenesis and
immunoregulation (see Fig. 4).
Animal studies are useful in understating the role of uNK cells
and macrophages in pregnancy complications, since uNK cells and
macrophages may play similar roles in the placental bed of rodents
as compared with humans. Such studies into the roles of uNK cells
in physiological and pathological development of the placental bed
may in the future result in (immune) therapies for pregnancy
complications.
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Fig. 4. The role of uNK cells and macrophages in the development of the placental bed. uNK cells and macrophages are both involved in spiral artery remodeling and production of
cytokines and other factors in the placental bed. uNK cell function may depend on the binding inhibitory and activating receptors of these cells HLA on EVT. Both cell types may
directly affect the vascular wall, although they may also indirectly affect the vascular wall by the production of cytokines and other factors. Macrophages may also aid in spiral artery
remodeling by clearance of apoptotic cells and cell debris and producing various tissue remodeling factors. Both cell types also have other functions in the decidua, such as
angiogenesis and immunoregulation.
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